[HTML][HTML] Auriculotemporal syndrome (Frey syndrome)
KM Motz, YJ Kim - Otolaryngologic Clinics of North America, 2016 - ncbi.nlm.nih.gov
Frey syndrome is a postoperative phenomenon following salivary gland surgery and less
commonly neck dissection, facelift procedures, and trauma that is characterized by gustatory …
commonly neck dissection, facelift procedures, and trauma that is characterized by gustatory …
Facial erythema of rosacea-aetiology, different pathophysiologies and treatment options
M Steinhoff, M Schmelz… - Acta dermato …, 2016 - epub.ub.uni-muenchen.de
Rosacea is a common chronic skin condition that displays a broad diversity of clinical
manifestations. Although the pathophysiological mechanisms of the 4 subtypes are not …
manifestations. Although the pathophysiological mechanisms of the 4 subtypes are not …
[PDF][PDF] Food allergy: a practice parameter
JA Chapman, IL Bernstein, RE Lee… - Annals of allergy …, 2006 - sipps.it
Food allergy, as defined for the purposes of this document, is a condition caused by an IgE-
mediated reaction to a food substance. Adverse reactions to foods may also occur due to …
mediated reaction to a food substance. Adverse reactions to foods may also occur due to …
Saliva and the control of its secretion
J Ekström, N Khosravani, M Castagnola… - … : Diagnosis and treatment, 2019 - Springer
The various functions of saliva—among them digestive, protective, and trophic ones—not
just limited to the mouth and the relative contribution of the different types of gland to the total …
just limited to the mouth and the relative contribution of the different types of gland to the total …
Clinical use of botulinum toxins in oral and maxillofacial surgery
OW Majid - International journal of oral and maxillofacial surgery, 2010 - Elsevier
Botulinum toxin (BTX) is a bacterial toxin that could be used as a medicine. Clinical
applications of BTX have been expanding over the last 30 years and novel applications …
applications of BTX have been expanding over the last 30 years and novel applications …
Impact of intradermal abobotulinumtoxinA on facial erythema of rosacea
BS Bloom, L Payongayong, A Mourin… - Dermatologic …, 2015 - journals.lww.com
BACKGROUND Facial erythema is a frequent and often distressing complaint of patients
with rosacea. Treatment of facial erythema with botulinum toxin has previously been …
with rosacea. Treatment of facial erythema with botulinum toxin has previously been …
Disorders of sweating
WP Cheshire, R Freeman - Seminars in neurology, 2003 - thieme-connect.com
The clinical spectrum of sweating disorders includes sudomotor excess and deficiency.
Hyperhidrosis is characterized by sweating beyond that required to maintain a constant …
Hyperhidrosis is characterized by sweating beyond that required to maintain a constant …
[PDF][PDF] A new treatment regimen for rosacea: onabotulinumtoxinA
SH Dayan, RN Pritzker, JP Arkins - J Drugs Dermatol, 2012 - researchgate.net
Worldwide, botulinum neuromodulators are now the most popular medical treatment for
wrinkle reduction, but its storied history and broad-based applications for treating many …
wrinkle reduction, but its storied history and broad-based applications for treating many …
Auriculotemporal Frey syndrome not associated with surgery or diabetes: systematic review
C Betti, GP Milani, SAG Lava, MG Bianchetti… - European journal of …, 2022 - Springer
Patients who undergo salivary gland, neck, or facelift surgery or suffer from diabetes mellitus
often develop Frey syndrome (also known as auriculotemporal syndrome or gustatory …
often develop Frey syndrome (also known as auriculotemporal syndrome or gustatory …
Botulinum toxin therapy: a tempting tool in the management of salivary secretory disorders
P Capaccio, S Torretta, M Osio, D Minorati… - American journal of …, 2008 - Elsevier
PURPOSE: The aim of the study was to investigate the feasibility and effectiveness of
botulinum toxin therapy in salivary secretory disorders. MATERIALS AND METHODS: We …
botulinum toxin therapy in salivary secretory disorders. MATERIALS AND METHODS: We …